Neurodegenrative changes in retina of rats with streptozotocin diabetes under different conditions of experimental treatment

Authors

  • N. V. Kresyun

DOI:

https://doi.org/10.14739/2310-1210.2014.4.27222

Keywords:

streptozotocin, diabetic retinopathy, delta sleep-inducing peptide, Electric Stimulation, Cerebellum

Abstract

Introduction. Diabetic retinopathy pathogenesis includes mechanisms of free radical generation and intensification of lipid peroxidation. It was shown that electrical stimulation (ES) of cerbellar structures as well as administration of delta-sleep inducing peptide (DSIP) is able both to alleviate intensified lipid peroxidation and cause neuroprotective action in neuronal tissue.

         The aim of research was to investigate the effectiveness of combined usage of DSIP and ES of paleocerebellar cortex upon neurodegenerative manifestations in retina of rats suffered from streptozotocin (STZ)- induced diabetes.

Methods of investigations. In Wistar rats diabetes have been modeled via i.p. STZ administration (55,0 mg/kg, i.p.). Electrical stimulations (ES) (100 Hz, 0,25 ms, 80-120 mcA, 2,5 s) of paleocerebellar cortex (V-VII lobules), which have been delivered during ten weeks two times daily (9.00; 19.00), started on 15th day from the moment of STZ  injection. DSIP («Sigma-Aldrich Chemie GmbH», Germany) have been administered every third day during ten weeks in a dosage of 50 mcg/ kg, i.p. Separate group of STZ-treated rats have been provided with combined usage of  DSIP and ES in mentioned dosage and regimen during ten weeks. Retinal hemotoxylin eosin painted slices (5 mcm) have been used for light microscopy and calculation of the number of neurons in retinal layers using digital photos. Results have been expressed as number of cells/mm2+SEM.

Results. Histological investigation of retina of rats with STZ diabetes revealed the net neurons vacuolization, along with edematic and picnotic deteriorations of neurons. Such disturbances were absent in intact rats and also less pronounced in groups of rats treated with DSIP and paleocerebellar ES. In rats with STZ-induced diabetes the outer nuclear layer contained less number of neurons – by 35,4% when compared with the same index in intact animals (P<0,05). Similar differences in diabetic rats treated with DSIP was 24,4% (P<0,05) and in rats treated with paleocerebellar ES – 28,3% (P<0,05). In rats treated with both DSIP and ES the reduction of number of neurons was 8,7% (P>0,05).  The number of neurons in the retinal inner nuclear layer of STZ-treated rats was reduced by 2,2 times pertained to intact rats (P<0,05). In groups of rats with DSIP administration and paleocerebellar ES the reduction was 1,94 and 1,8 times correspondently when compared with the intact rats (P<0,05). Combined usage of DSIP and paleocerebellar ES was followed by the prevalence in number of neurons by 53,1% pertained to the similar index in STZ-treated animals (P<0,05). At the same time the number of neurons in inner nuclear layer was still diminished by 30,8% when compared to intact animals (P<0,05). The number of neurons in retinal ganglionar layer in STZ- treated rats was reduced by 2,1 times in comparison with the similar data in intact rats (P<0,05). The reduction of investigated index by 1,79 and 1,93 times was observed in diabetic rats treated with DSIP and ES correspondently (P<0,05). Combined usage of DSIP and ES in STZ-treated rats was followed by prevalence of the number of neurons by 36,9% when compared to the data in STZ-treated rats (P<0,05). At the same time the investigated index was reduced by 34,4% in comparison with the such one registered in intact animals (P<0,05).

Conclusions.

1.The development of STZ-induced diabetes is connected with neurodegenerative changes in retina, which is most pronounced in the outer nuclear layer.

2. The combined usage of DSIP and ES of paleocerebellar cortex is followed by the pronounced neurtoprotective action under condition of experimental STZ- induced diabetes.


 

References

Vojtenkov, V. B. & Mikhaleva, I. I. (2011). Del'ta-son induciruyushhij peptid: itogi i perspektivy [Delta sleep inducing peptide: results and perspectives]. Saarbrucken: LAP Lambert Academic Publishing. [in Germany].

Kresyun, N. V. (2013). Patofiziologicheskie mekhanizmy formirovaniya diabeticheskoj retinopatii i obosnovanie podkhodov k ee terapii [Patophysiological mechanisms of diabetic retinopathy formation and justifying of the approaches to methods of it’s treatment. Integrative Antropology]. Integrativnaja antropologija , 21, 43–48. [in Ukrainian].

Kresyun, N. V. (2014). Gistologicheskie izmeneniya setchatoj obolochki glaza pri e`ksperimental'nom saharnom diabete v usloviyakh primeneniya del'ta son-induciruyuschego peptida [Histological deterioration of retina under conditions of experimental diabetes and delta-sleep inducing peptide adiministrations]. Svit meditsiny i Biologii, 44, 124–127. [in Ukrainian].

Kresyun, N. V. (2014).Perekysne okysnennia lipidiv u sitkivtsi oka shchuriv zi streptozotsyn-indukovabym diabetom za umov elektrychnoho podraznennia paleotserenralnoi kory [Lipid peroxidation in retina of rats with streptozotocin – induced diabetes under conditions of paleocerebellum electrical stimulation]. Odeskyi medychnyi zhurnal, 141, 26–30. [in Ukrainian].

Bondarenko, T. I., Maiboroda, Е. А., Mikhaleva, I. I., & Prudchenko, I. A. (2013). Metabolicheskie e`ffekty del'ta-son induciruyushhego peptida pri fiziologicheskom starenii [Metabolic effects of delta-sleep inducing peptide in course of physiological aging]. E`ksperimental'naya i klinicheskaya farmakologiya, 9, 22–26. [in Russian].

Antonetti, D. A., Klein, R., & Gardner, T. W. (2012). Diabetic retinopathy. Engl.J.Med., 366(13), 1227–1239. doi: 10.1056/NEJMra1005073.

Shen, J. H., Ma, Q., Shen, S. G., Xu, G. T., & Das, U. N. (2013). Effect of alpha-linolenic acid on streptozotocin – induced diabet retinopathy indices in vivo. Archives of Medical Research, 44(7), 514–520. doi: 10.1016/j.arcmed.2013.09.010.

Guizzo, R., Cairrao, M. A. R., Coutnho-Netto, J., de Silva, A. R. M., Coimbra, N. C., & dos Santos, W. F. (2005). Neuroprotection in acute ischemia and ischemia| reperfusion in rat retina. Internat.J.of Pharmacol., 1(5), 369–365.

Gong, C. Y., Lu, B., Hu, Q. W., Ji, L. L. (2013). Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor Internat. J. of Ophthalmology, 6(5), 573–577.

How to Cite

1.
Kresyun NV. Neurodegenrative changes in retina of rats with streptozotocin diabetes under different conditions of experimental treatment. Zaporozhye Medical Journal [Internet]. 2014Sep.5 [cited 2024Dec.22];16(4). Available from: http://zmj.zsmu.edu.ua/article/view/27222

Issue

Section

Original research